ApprovalTrail

Approval · Notice of Compliance 1682 · 2001

PROLEUKIN: Notice of Compliance 1682

Issued April 26, 2001

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
1682
Date
April 26, 2001
Product type
Biologic
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Change in manufacturer name
Therapeutic class
Biologic response modifier

Products in this notice

BrandDINStatus today
PROLEUKIN02130181Marketed

Medicinal ingredients